STOCK TITAN

RMD (RMD) insider Michael Farrell files to sell 4,991 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Michael Farrell filed a notice to sell 4,991 shares of RMD common stock through Fidelity Brokerage Services LLC on January 7, 2026, with an aggregate market value of $1,240,065.29 on the NYSE.

The shares were acquired the same day via a cash exercise of a stock option originally granted on November 21, 2019. RMD has 145,966,294 common shares outstanding, and over the prior three months Farrell sold 8,009, 8,011, and 4,991 common shares in separate transactions, generating gross proceeds of $2,265,332.03, $2,000,772.95, and $1,254,795.79, respectively.

Positive

  • None.

Negative

  • None.

Insights

Routine insider Form 144 sale with prior monthly sales disclosed.

This notice shows Michael Farrell planning to sell 4,991 RMD common shares, valued at about $1,240,065.29, on January 7, 2026. The shares come from a stock option granted on November 21, 2019 and exercised for cash on the same day as the planned sale.

The filing also lists prior sales over the last three months: 8,009, 8,011, and 4,991 shares of common stock, with gross proceeds of $2,265,332.03, $2,000,772.95, and $1,254,795.79. RMD has 145,966,294 common shares outstanding, so the disclosed transactions represent a small fraction of total shares. Such filings are often administrative disclosures of insider liquidity rather than signals about business performance.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many RMD shares is Michael Farrell planning to sell under this Form 144?

The notice states that Michael Farrell plans to sell 4,991 shares of RMD common stock, with an aggregate market value of $1,240,065.29.

When will the 4,991 RMD shares be sold and on which exchange?

The planned sale date is January 7, 2026, and the 4,991 common shares are listed to be sold on the NYSE.

How did Michael Farrell acquire the RMD shares being sold in this Form 144?

The 4,991 common shares were acquired on January 7, 2026 through a cash exercise of a stock option originally granted on November 21, 2019.

How many RMD shares has Michael Farrell sold in the last three months?

Over the past three months, the filing reports sales of 8,009 shares on October 7, 2025, 8,011 shares on November 7, 2025, and 4,991 shares on December 8, 2025.

What total gross proceeds did Michael Farrell receive from recent RMD share sales?

The filing lists gross proceeds of $2,265,332.03, $2,000,772.95, and $1,254,795.79 from the October, November, and December 2025 sales, respectively.

How many RMD common shares are outstanding according to this Form 144?

The Form 144 indicates there are 145,966,294 RMD common shares outstanding.
Resmed

NYSE:RMD

RMD Rankings

RMD Latest News

RMD Latest SEC Filings

RMD Stock Data

38.05B
145.22M
0.79%
64.76%
5.81%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SAN DIEGO